Adynovate and Brentuximab Intravenous
Determining the interaction of Adynovate and Brentuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate-Brentuximab vedotin
- Adynovate-Breo Ellipta
- Adynovate-Brethine
- Adynovate-Brethine Subcutaneous
- Adynovate-Bretylium
- Adynovate-Bretylium Injection
- Brentuximab Intravenous-Adynovate recombinant
- Brentuximab Intravenous-Adzenys ER
- Brentuximab Intravenous-Adzenys ER Oral Suspension
- Brentuximab Intravenous-Adzenys XR-ODT
- Brentuximab Intravenous-Aemcolo
- Brentuximab Intravenous-Aerobid